Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,894 | 341 | 97.5% |
| Education | $150.50 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $865.87 | 49 | $0 (2024) |
| Alkermes, Inc. | $800.84 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $775.81 | 57 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $653.55 | 38 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $557.03 | 27 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $480.18 | 22 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $475.77 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $385.83 | 25 | $0 (2024) |
| ITI, Inc. | $376.35 | 27 | $0 (2023) |
| IRONSHORE PHARMACEUTICALS INC. | $139.63 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,010 | 110 | Supernus Pharmaceuticals, Inc. ($457.53) |
| 2023 | $1,754 | 99 | ABBVIE INC. ($333.89) |
| 2022 | $1,296 | 77 | Alkermes, Inc. ($240.42) |
| 2021 | $983.79 | 57 | AbbVie Inc. ($220.97) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.23 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $15.60 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: CNS | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.83 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/05/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: CNS | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: CNS | ||||||
| 10/23/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/14/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Neurology | ||||||
| 09/25/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 51 | 226 | $39,056 | $12,727 |
| 2022 | 3 | 96 | 325 | $40,790 | $17,624 |
| 2021 | 3 | 79 | 126 | $14,801 | $6,805 |
| 2020 | 1 | 16 | 54 | $5,360 | $2,544 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 167 | $31,511 | $10,729 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 59 | $7,545 | $1,997 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 181 | $27,150 | $11,853 | 43.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 31 | 74 | $6,290 | $3,172 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 70 | $7,350 | $2,598 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 45 | $6,750 | $3,435 | 50.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 25 | 47 | $4,559 | $2,256 | 49.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 34 | $3,492 | $1,114 | 31.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 54 | $5,360 | $2,544 | 47.5% |
About Stacy Dycus
Stacy Dycus is a Psychiatric/Mental Health healthcare provider based in Clarksville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2019. The National Provider Identifier (NPI) number assigned to this provider is 1710529136.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacy Dycus has received a total of $6,044 in payments from pharmaceutical and medical device companies, with $2,010 received in 2024. These payments were reported across 343 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,894).
As a Medicare-enrolled provider, Dycus has provided services to 242 Medicare beneficiaries, totaling 731 services with total Medicare billing of $39,699. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Clarksville, TN
- Active Since 10/17/2019
- Last Updated 10/17/2019
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1710529136
Products in Payments
- VRAYLAR (Drug) $865.87
- INVEGA SUSTENNA (Drug) $751.01
- ARISTADA (Drug) $731.82
- INGREZZA (Drug) $557.03
- HETLIOZ (Drug) $480.18
- CAPLYTA (Drug) $466.66
- Qelbree (Drug) $457.53
- Austedo XR (Drug) $250.43
- REXULTI (Drug) $209.35
- UZEDY (Drug) $199.03
- JORNAY PM (Drug) $139.63
- ABILIFY MAINTENA (Drug) $131.98
- AUSTEDO (Drug) $131.59
- Azstarys (Drug) $121.62
- LATUDA (Drug) $82.48
- ABILIFY ASIMTUFII (Drug) $64.60
- Auvelity (Drug) $62.85
- LYBALVI (Drug) $44.50
- ADHANSIA XR (Drug) $30.06
- SUNOSI (Drug) $27.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Clarksville
Candise Belmont, Aprn, APRN
Psychiatric/Mental Health — Payments: $4,709
Ms. Amy Summers, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $3,616
Mrs. Kayla Mcmanus, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $2,922
Mr. Arthur Lyman, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $2,103
Elizabeth Burton, Msn, Pmhnp-Bc, MSN, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,791
Ms. Alexandra Popova, Rn,Msn, RN,MSN
Psychiatric/Mental Health — Payments: $1,735